Clinical Trial 5575

Las Vegas, NV 89103

Study Summary:

We are currently conducting a phase 3 randomized, double blind placebo and Naproxen controlled for safety and analgesic efficacy of Tenezumab ( a NGF Monoclonal IgG2 Antibody)

24 week of study with I. V. injections over five minutes period. At every 8 week intervals.

After 24 week completion subjects will be able to rollover to extension period for up to one year if eligible.

Qualified Participants May Receive:

All study related medical exams, EKG's, lab work and neurological exams by board certified physician are free. Compensation for time and travel provided.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.